Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Neoplasms 1Neoplasm Metastasis 1KRAS p.G12C Mutant Advanced Solid Tumors 1KRAS p, G12c Mutated /Advanced Metastatic NSCLC 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 3Taxes 2Radiotherapy 2Radiosurgery 2Radiation 2Paclitaxel 2Nivolumab 2veliparib 1tislelizumab 1spartalizumab 1sotorasib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1enzalutamide 1apatinib 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Platinum 1Pemetrexed 1Morphine 1Midazolam 1Letrozole 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Fulvestrant 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma of Lung × sotorasib × Clear all
NCT04625647 2025-12-05

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

SWOG Cancer Research Network

Phase 2 Active not recruiting
116 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡